新闻
BLFS
--
0.00%
--
COO Of Biolife Solutions Makes $1.1M Sale
De De, COO at Biolife Solutions (NASDAQ:BLFS), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that De sold 21,000 shares of Biolife...
Benzinga · 11/19 16:50
Biolife Solutions Inc (BLFS) COO & President Greef Roderick De Sold $1.1 million of Shares
GuruFocus News · 11/19 14:15
著名的 Biolife Solutions Insider 交易了 100 万美元的公司股票
Aby J Mathew, Insider at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on November 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Aby J Mathew ex...
Benzinga · 11/18 15:31
Biolife Solutions Inc (BLFS) EVP & Chief Scientific Officer Aby J. ...
GuruFocus News · 11/18 13:15
BioLife Solutions 在 2021 Deloitte Technology Fast 500™ 中在北美增长最快的公司中排名 353
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced it has ranked 353 in the 27th annual Deloitte Technology Fa...
PR Newswire · 11/17 18:08
BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies and the broader biopharma markets, today announced that it was named...
PR Newswire · 11/15 13:05
BioLife Solutions EPS beats by $0.09, beats on revenue
BioLife Solutions (NASDAQ:BLFS): Q3 GAAP EPS of $0.00 beats by $0.09. Revenue of $33.8M (+199.1% Y/Y) beats by $2.21M. Press Release Raises full-year 2021 revenue guidance to $115 to $119
Seekingalpha · 11/11 21:36
BioLife Solutions Q3 EPS $(0.19) Misses $(0.09) Estimate, Adj. EBITDA Loss $2.1M, Sales $33.80M Beat $31.61M Estimate
BioLife Solutions (NASDAQ:BLFS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent. This is a 850 percent decrease over losses of $(0.02) per share
Benzinga · 11/11 21:13
BioLife Solutions Q3 调整后亏损扩大,即使收入几乎翻了三倍; 2021年销售指导提高
MT Newswires · 11/11 17:00
-- Earnings Flash (BLFS) BIOLIFE SOLUTIONS Posts Q3 Revenue $33.8M, vs. Street Est of $31.6M
MT Newswires · 11/11 16:22
BioLife Solutions Q3 2021 Earnings Preview
BioLife Solutions (NASDAQ:BLFS) is scheduled to announce Q3 earnings results on Thursday, November 11th, after market close. The consensus EPS Estimate is -$0.00 (+100.0% Y/Y) and the consensus Revenue Estimate
Seekingalpha · 11/10 22:35
Notable earnings after Thursday's close
ACHR, AEYE, AGRO, DADAAQN, ARRY, ASTR, AVGR, AVIR, BEEM, BLFS, BLNK, OTCPK:BOWFF, CODX, CPNG, OTCPK:EIFZF, FLO, GAN, GOVX, GP, HYFM, OTCQB:IGXT, INTZ, INUV, JAMF, JOBY, LAZR, LTRX, MAPS, OTC:NWHUF, ONTX,
Seekingalpha · 11/10 22:35
日内瓦资本管理有限公司收购 Construction Partners Inc、Onto Innovation Inc、Semtech ...
GuruFocus News · 11/08 17:38
Horan Capital Advisors, LLC. Buys TJX Inc, BioLife Solutions Inc, iShares Core S&P ...
GuruFocus News · 11/08 13:38
Biolife Solutions Inc (BLFS) CEO Michael Rice Sold $1.3 million of Shares
GuruFocus News · 11/05 12:15
Insider Sell: Biolife Solutions
MT Newswires · 11/05 12:08
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Zacks.com · 11/05 10:20
BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2021 financial results will be ...
PR Newswire · 11/04 12:03
What Is The Ownership Structure Like For BioLife Solutions, Inc. (NASDAQ:BLFS)?
A look at the shareholders of BioLife Solutions, Inc. ( NASDAQ:BLFS ) can tell us which group is most powerful...
Simply Wall St. · 11/04 11:34
Biolife Solutions 通过 SciSafe 的“卓越中心”和阿姆斯特丹的新世界级设施支持生物存储最佳实践
/PRNewswire/ -- Biolife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for cell and gene therapies...
PR Newswire · 10/26 12:05
微牛提供丰富的实时BLFS股票新闻,让你可以通过多个平台了解BLFS股票行情最新动态,这些免费的BioLife新闻可以帮助你做出明智投资。
BLFS 简况
BioLife Solutions, Inc.(BioLife)致力于开发、制造和营销用于细胞、组织和器官的生物保存工具和服务组合,包括临床级细胞和组织低温储存和冷冻保存冷冻培养基以及相关的云托管生物制剂 托运人的连锁管理申请。该公司的产品包括用于细胞、组织和器官的低温储存和冷冻保存冷冻培养基产品、通用血液干细胞冷冻和细胞解冻培养基产品、定制产品配方和定制包装服务、冷链物流服务,其中包括精密热包装产品和云托管的Web应用程序,并签订液体媒体产品的无菌制造配方、填充和完成服务。其产品包括HypoThermosol FRS、CryoStor、BloodStor、Cell Thawing Media、PrepaStor和biologistex冷链管理服务。